Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ucb Pharma Aktiebolag (Sweden)
AB
Active
Org 5560711185
Olof Palmes Gata 29, 111 22
Stockholm
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1960
20-49 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Ucb Pharma Aktiebolag (Sweden)
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
76M
152M
228M
304M
190M
2020
200M
2021
211M
2022
233M
2023
264M
2024
EBITDA
SEK millions
0M
4M
7M
11M
15M
9M
2020
10M
2021
10M
2022
12M
2023
13M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
189 893
199 742
211 447
233 450
264 177
Staff expenses
—
—
—
—
—
EBITDA
9 109
9 929
10 492
12 185
13 204
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
9 109
9 929
10 492
12 185
13 204
Net financials
123
−181
−643
−17
−525
Profit before tax
9 232
9 831
10 169
12 192
12 810
Tax
−2 052
−2 209
−2 517
−2 627
−2 839
Net profit
7 180
7 622
7 652
9 565
9 971
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
119 677
115 250
132 139
168 065
166 615
Equity
53 900
61 522
61 575
63 440
63 911
Long-term debt
0
0
0
0
0
Short-term debt
65 777
53 728
70 564
104 625
102 704
Total debt
65 777
53 728
70 564
104 625
102 704
Financial ratios
5-year trend
EBITDA margin
5.0%
This company
15.8%
Market median
-68% vs market
2020
2024
Equity ratio
38.4%
This company
38.2%
Market median
+1% vs market
2020
2024
Return on equity
15.6%
This company
18.4%
Market median
+15% vs market
2020
2024
Net profit margin
3.8%
This company
8.1%
Market median
-53% vs market
2020
2024
Asset turnover
1.59×
This company
1.12×
Market median
+42% vs market
2020
2024
Debt / equity
1.61×
This company
0.62×
Market median
-160% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Ucb Pharma Aktiebolag (Sweden)
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
